2-(5,6-difluoro-3-hydroxy-1H-inden-1-ylidene)propanedinitrile, 97%, 250mg

Fermetures à vis GLS 80, 1 pièce

Polyethylene Glycol Monocetyl Ether (n=approx. 23) [for Biochemical Research]5g

1-Pentyl-1H-indole, 95.0%, 250mg

METHYL 6-BROMO-3-FORMYL-1H-INDOLE-4-CARBOXYLATE, 95.0%, 5g

2-Cyclopropyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine, 95.0%, 100mg

5-Amino-2-methoxy-4-methyl pyridine, 97.0%, 500g

Octahydrocyclopenta[c]pyrrole hydrochloride, 98.0%, 25g

(R)-2-((tert-Butoxycarbonyl)amino)-3-(4-iodophenyl)propanoic acid, 98.0%, 25g

N-Boc-2-Amino-5-bromothiazole-4-carboxylic acid, 95.0%, 5g

7-Chloro-1,2,3,4-tetrahydroquinolin-4-amine, 95.0%, 250mg

6-Bromo-1H-pyrrolo[3,2-b]pyridin-3-amine, 97%, 5g

3-Azabicyclo[3.1.1]heptane hydrochloride, 95.0%, 1g